Low dose radiopharmaceutical therapy enhances CAR T therapy in neuroblastoma models
Amanda Shea
Advisor: Zach Morris, MD, PhD
Combined inhibition of MEK and HDACs enhances anti- leukemia cytotoxicity of T cells
Meher Bolisetti, PhD
Zhang Lab
6571 WIMR II
@ 3:30 pm - 4:30 pm
Low dose radiopharmaceutical therapy enhances CAR T therapy in neuroblastoma models
Amanda Shea
Advisor: Zach Morris, MD, PhD
Combined inhibition of MEK and HDACs enhances anti- leukemia cytotoxicity of T cells
Meher Bolisetti, PhD
Zhang Lab